Restatement of Previously Reported Financial Statements - Summary of Effect of Correcting Error in Balance Sheets (Details) - USD ($)	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 4,739,426	$ 5,964,826	$ 7,006,431		$ 9,843,699
Accounts receivable, net	673,071				624,832
Prepaid expenses	885,040	37,855	371,348		952,954
Inventory	481,840	504,925	513,712		289,378
Other current assets	47,532	98,094	11,551		11,551
Total current assets	6,826,909	7,839,604	8,926,855		11,722,414
Deferred offering costs	241,637
Total assets	7,068,546	7,852,974	8,979,697		11,851,488
Current Liabilities:
Accounts payable and accrued expenses	1,711,778	1,397,442	1,415,309		934,312
Accrued compensation	1,324,010	829,669	612,932		591,158
Note payable	5,000,000	5,000,000	5,000,000
Accrued interest payable	1,612,295	1,486,268	1,360,240
Total current liabilities	9,648,083	8,726,749	8,441,323		1,654,544
Long-term liabilities
Note payable					5,000,000
Accrued interest payable					1,112,295
Total long-term liabilities					6,112,295
Total liabilities	9,648,083	8,726,749	8,441,323		7,766,839
Commitments and contingencies
Stockholders' deficit:
Preferred stock
Common stock	334	334	334		334
Additional paid-in capital	120,859,567	120,577,928	120,296,170		119,731,458
Accumulated deficit	(123,439,438)	(121,452,037)	(119,758,130)		(115,647,143)
Total stockholders' equity (deficit)	(2,579,537)	(873,775)	538,374	$ 2,100,000	4,084,649	$ 3,555,094
Total liabilities and stockholders' equity (deficit)	7,068,546	7,852,974	8,979,697		$ 11,851,488
As Previously Reported [Member]
Current Assets:
Cash and cash equivalents	4,739,426	5,964,826	7,006,431
Accounts receivable, net	673,071
Prepaid expenses	885,040	37,855	371,348
Inventory	481,840	504,925	513,712
Other current assets	47,532	98,094	11,551
Total current assets	6,826,909	7,839,604	8,926,855
Deferred offering costs	241,637
Total assets	7,068,546	7,852,974	8,979,697
Current Liabilities:
Accounts payable and accrued expenses	1,711,778	1,397,442	1,415,309
Accrued compensation	1,324,010	829,669	612,932
Total current liabilities	3,035,788	2,240,481	2,081,083
Long-term liabilities
Note payable	5,000,000	5,000,000	5,000,000
Accrued interest payable	1,612,295	1,486,268	1,360,240
Total long-term liabilities	6,612,295	6,486,268	6,360,240
Total liabilities	9,648,083	8,726,749	8,441,323
Commitments and contingencies
Stockholders' deficit:
Preferred stock
Common stock	334	334	334
Additional paid-in capital	120,859,567	120,577,928	120,296,170
Accumulated deficit	(123,439,438)	(121,452,037)	(119,758,130)
Total stockholders' equity (deficit)	(2,579,537)	(873,775)	538,374
Total liabilities and stockholders' equity (deficit)	7,068,546	$ 7,852,974	$ 8,979,697
Restatement Impact [Member]
Current Liabilities:
Note payable	5,000,000
Accrued interest payable	1,612,295
Total current liabilities	6,612,295
Long-term liabilities
Note payable	(5,000,000)
Accrued interest payable	(1,612,295)
Total long-term liabilities	(6,612,295)
Commitments and contingencies
Stockholders' deficit:
Preferred stock